Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT02863328 · COMPLETED
Trial details
- NCT number
- NCT02863328
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-10
- Primary completion
- 2017-08-01
- Enrollment
- 822
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.